UK Independent Finance Intelligence · Est. 2024
Updated daily Newsletter For business
Home Money Guides Weight Loss Injection Cost UK 2026: Ozempic, Wegovy & Mounjaro
Money Guides

Weight Loss Injection Cost UK 2026: Ozempic, Wegovy & Mounjaro

CT
Chandraketu Tripathi
Finance Editor, Kaeltripton
Published 2 Apr 2026
Last reviewed 18 May 2026
✓ Fact-checked
Weight Loss Injection Cost UK 2026: Ozempic, Wegovy & Mounjaro
Advertisement

Key facts (2026): Wegovy (semaglutide) costs approximately £200–£250 per month privately in the UK for the maintenance dose. Mounjaro (tirzepatide) costs £175–£225 per month. NHS prescribing is available through specialist weight management services for those meeting strict criteria. Ozempic (also semaglutide) is licensed for diabetes only in the UK, not for weight loss, though it is sometimes prescribed off-label.

Weight loss injections — GLP-1 receptor agonists — have transformed obesity treatment globally. In the UK, demand has exploded but NHS access remains tightly rationed. Most people are accessing these medications through private online pharmacies and weight loss clinics, at significant monthly cost.

Wegovy (Semaglutide) Cost UK 2026

Wegovy is licensed in the UK for weight management in adults with a BMI of 30+ (or 27+ with at least one weight-related condition). Private monthly costs: 0.25mg starter dose: ~£130–£160/month; maintenance dose (2.4mg): ~£200–£260/month. Available from private clinics and online pharmacies including Superdrug Health, ZAVA, and Boots Online Doctor. Always use a regulated UK provider — avoid unregulated overseas suppliers.

Mounjaro (Tirzepatide) Cost UK 2026

Mounjaro was approved in the UK for weight management in 2023 and is available privately at approximately £175–£225/month at maintenance doses. Clinical trial data shows Mounjaro produces greater average weight loss than Wegovy (approximately 20–22% body weight vs 15% for Wegovy). Private availability is good through most major online pharmacies.

NHS Access — Who Qualifies?

NHS prescribing of Wegovy and Mounjaro for weight management is available through specialist NHS weight management services (Tier 3 or Tier 4) for patients meeting strict criteria: typically BMI 35+ (or 30+ with serious comorbidities), having completed a structured weight management programme, and being under specialist care. Waiting times for NHS Tier 3 services are typically 6–18 months. GP prescribing for weight loss injections on the NHS remains very limited outside specialist pathways.

Our Verdict

Weight loss injections are clinically effective — average weight loss of 15–22% of body weight in trials — but expensive at £175–£260/month privately. For those meeting NHS criteria, the specialist pathway is worth pursuing despite the wait. For private use, only purchase from regulated UK pharmacies registered with the MHRA and CQC. Never buy from unregulated online sources — counterfeit products are a genuine risk.

Frequently Asked Questions

How much does Wegovy cost UK 2026?

Approximately £200–£260 per month at the maintenance dose from private UK providers.

Is Mounjaro available on NHS UK?

Through specialist NHS weight management services for those meeting strict BMI and clinical criteria. GP prescribing is very limited.

What is the difference between Ozempic and Wegovy?

Both contain semaglutide. Ozempic is licensed for type 2 diabetes in the UK; Wegovy is licensed specifically for weight management at a higher dose (2.4mg vs 1mg for Ozempic).


Disclaimer: For informational purposes only. Verify with gov.uk or qualified professionals before making decisions.

Last updated: April 2026 · Author: Chandraketu Tripathi

Advertisement

Editorial Disclaimer

The content on Kaeltripton.com is for informational and educational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Kaeltripton.com is not authorised or regulated by the Financial Conduct Authority (FCA) and is not a financial adviser, mortgage broker, insurance intermediary or investment firm. Nothing on this site should be construed as a personal recommendation. Rates, figures and product details are indicative only, subject to change without notice, and should always be verified directly with the relevant provider, HMRC, the FCA register, the Bank of England, Ofgem or other appropriate authority before any financial decision is made. Past performance is not a reliable indicator of future results. If you require regulated financial advice, please consult a qualified adviser authorised by the FCA.

CT
Chandraketu Tripathi
Finance Editor · Kaeltripton.com
Chandraketu (CK) Tripathi, founder and lead editor of Kael Tripton. 22 years in finance and marketing across 23 markets. Writes on UK personal finance, tax, mortgages, insurance, energy, and investing. Sources: HMRC, FCA, Ofgem, BoE, ONS.

Stay ahead of your money

Free UK finance guides, rate changes and money-saving tips — straight to your inbox. No spam, unsubscribe anytime.

Read More

Get Kael Tripton in your Google feed

⭐ Add as Preferred Source on Google